← Latest news 
Indian pharma giant joins the weight loss race with a new obesity drug find
Business
Published on 24 April 2026
The surprise is how fast it could scale globally
Weight-loss drugs have become a high-stakes global opportunity, and now a major Indian pharma player is stepping into the obesity fight with a fresh drug development. The move signals intensifying competition as companies chase demand for effective treatments, where speed to scale, manufacturing reach, and clinical promise could decide who leads the next wave of obesity medicines worldwide.
- An Indian pharma giant is adding momentum to global obesity drug efforts
- Weight-loss therapeutics are emerging as a major growth opportunity
- Competition is likely to intensify as more players enter the market
- Global scaling and treatment effectiveness will be key to winning demand
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times